Device Aimed at Early Detection of Deadly Diseases Wins NJ Health Foundation Grant
The New Jersey Health Foundation has awarded an innovation grant to develop a nanotechnology-enhanced biochip to help detect deadly diseases.
Read More
Search Results for: prostate cancer
Digital Pathology Gives Rise to Computational Pathology
Artificial intelligence is reshaping the capabilities and practices of modern pathology laboratories.
Read More
Bio-Rad Adds New Analytes to Tumor Marker Control
The updated control has received FDA premarket notification (510(k)) clearance and CE marking, and is available for the immunoassay-based tumor marker testing market.
Read MoreLiquid Biopsy at a Glance
A number of oncology centers have developed and implemented liquid biopsy tests not only for lung cancer, but for breast, colorectal, gynecologic, ovarian, prostate, and skin cancers as well.
Read More
May 2017 Product Spotlight: Immunoassay Analyzers
This month’s issue features immunoassay analyzers from such companies as Arlington Scientific and Dynex Technologies.
Read More